BioSpace News Archive

Jasper Therapeutics, Inc. announced the appointment of Matthew Ford as the Company’s Vice President, Human Resources.

Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces it will be attending the 43rd International Society for Heart and Lung Transplant (ISHLT) Annual Meeting and Scientific Sessions, which brings together the world’s leading experts in heart and lung transplant being held at the Colorado Convention Center, from April 19-22, in Denver, CO.

4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a clinical-stage biotherapeutics company harnessing the power of directed evolution for targeted genetic medicines

Ocean Biomedical, Inc. announced that its Scientific Co-founder and a member of its board of directors, Jonathan Kurtis, MD, PhD, received a Notice of Allowance from the United States Patent and Trademark Office for his U.S. patent application covering a therapeutic and prophylactic monoclonal antibody that kills falciparum malaria parasites.

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will host a webcast conference call to report its first quarter 2023 financial results and provide an update on the company’s business and outlook on Thursday, April 27, at 4:30 p.m. ET.

Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, today announced the appointment of Rafael G. Amado, M.D., to its Board of Directors, effective today.

YDS Pharmatech today announced the appointment of Dr. Robert Sullivan as Head of Medicinal Chemistry.

IGM Biosciences, Inc. announced the presentation of six posters at the upcoming American Association for Cancer Research Annual Meeting 2023, taking place in Orlando, Florida on April 14-19, 2023.

Sight Sciences, Inc., an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, announced it will host a Surgical Glaucoma Investor Symposium in San Diego, CA on Friday, May 5, 2023 at 6:00 pm PT.

MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today reported financial results for the three months and full-year ended December 31, 2022.